Quotes NEOVACS SA Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 02:06:03 2023-11-15 EST			5-day change	1st Jan Change
0.000500 ^EUR	-.--%		-.--%	-

06-30	Neovacs bolsters its strategic intellectual property portfolio
02-10	Neovacs S.A. announced that it has received ?0.25 million in funding from Hanover Square Investments Pte Limted	CI

Stock exchange

Deutsche Boerse AG 0LW 0.000500 € -.--% 0 €

Markets		Price	Change	Volumes
Euronext Paris	ALNEV	0.6102EUR	-0.29%	10.67K €
Boerse Muenchen	0LW1	0.6700EUR	+24.07%	6.03 €
Deutsche Boerse AG	0LW1	0.1120EUR	0.00%	0 €
Börse Stuttgart	0LW1	0.4900EUR	-19.67%	0 €

3 months

-99.04%

markets

Capital turnover ratio

Float rotation

Market Cap (EUR)

97,429

Market Cap (USD)

113,643

Net sales ()

433,937

Net sales (USD)

506,153

Free-Float

99 %

Free-Float capitalization (EUR)

2,271

Free-Float capitalization (USD)

2,649

Moving average 5 days

Moving average 100 days

884.44

Price spread / (MMA5)

+999,900.00%

Price spread / (MMA100)

+176,888,780.00%

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEOVACS SA	-.--%	-.--%	-	-	114K
LONZA GROUP AG	-0.74%	+4.48%	+3.74%	+22.46%	51.61B
REVOLUTION MEDICINES, INC.	+1.01%	+3.86%	+471.68%	+577.49%	44.89B
IQVIA HOLDINGS INC.	+0.16%	+9.96%	+36.14%	+20.40%	42.77B
BEONE MEDICINES AG	-0.66%	+7.05%	+18.59%	+83.42%	42.58B
CELLTRION, INC.	+0.88%	-3.48%	+17.20%	+57.20%	31.82B
MEDPACE HOLDINGS, INC.	-0.12%	+7.18%	+33.73%	+148.24%	17.33B
ASCENDIS PHARMA A/S	-0.53%	+1.39%	-	-	16.63B
EUROFINS SCIENTIFIC SE	+0.58%	+4.00%	+7.17%	+30.59%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.15%	+6.62%	+84.49%	+47.81%	14.09B
Average	+0.19%	+4.83%	+84.09%	+123.45%	27.65B
Weighted average by Cap.	+0.10%	+5.13%	+100.58%	+142.48%